IndustryCompany release

Akebia secures up to $140M Symbiotic Capital term loan, repays $55M BlackRock facility

🇺🇸 Akebia Therapeutics, Inc. (AKBA) · Mon 16 Nov 2026

Akebia Therapeutics announced a senior secured term loan with Symbiotic Capital, closed November 12, 2026 and disclosed November 16, 2026. A $60 million initial tranche was funded and used to repay its $55 million BlackRock loan in full, and up to $80 million more may be provided at the lender's discretion. The loan matures in 60 months at a variable rate of at least 11.5%, and the company reaffirmed cash runway guidance of at least two years.

Company's press release (SEC filing): Akebia Therapeutics, Inc. ↗

Brief written by VigiEye from the company's press release filed with the SEC. Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →